Genmab A/S
GMAB
$31.94
$0.601.91%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 06/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -- | 1.30B | 1.30B |
| Total Depreciation and Amortization | -- | -- | -- | 55.14M | 59.14M |
| Total Amortization of Deferred Charges | -- | -- | -- | 12.00M | 8.00M |
| Total Other Non-Cash Items | -- | -- | -- | -184.27M | -184.27M |
| Change in Net Operating Assets | -- | -- | -- | -105.99M | -105.99M |
| Cash from Operations | -- | -- | -- | 1.07B | 1.07B |
| Capital Expenditure | -- | -- | -- | -41.69M | -41.69M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -82.99M | -82.99M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 80.38M | 80.38M |
| Cash from Investing | -- | -- | -- | -44.30M | -44.30M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -23.67M | -23.67M |
| Issuance of Common Stock | -- | -- | -- | 52.62M | 52.62M |
| Repurchase of Common Stock | -- | -- | -- | -745.49M | -745.49M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -481.21M | -481.21M |
| Foreign Exchange rate Adjustments | -- | -- | -- | 25.03M | 25.03M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -- | 571.79M | 571.79M |